Study of the effect of direct/grid laser photocoagulation and intravitreal ranibizumab in patients with macular edema following retinal vein occlusion

Study of the effect of direct/grid laser photocoagulation and intravitreal ranibizumab in patients with macular edema following retinal vein occlusion - Combination therapy of direct/grid laser photocoagulation and intravitreal Ranibizumab in patients with macular edema following retinal vein occlusion

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016308

Enrollment

Registered

2015-01-25

Start date

2014-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinal vein occlusion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients with macular edema following retinal vein occlusion

Exclusion criteria

Exclusion criteria: Prior ocular treatment within 3 months before initial intravitreal ranibizumab History or presence of other ocular deseases causing vision deterioration

Design outcomes

Primary

Measure	Time frame
visual acuity, central subfield macular thickness, number of intravitreal ranibizumab injections	—

Countries

Japan

Contacts

Public ContactYasuhiro Iesato

Shinshu university school of medicine Department of Ophthalmology

iesato@shinshu-u.ac.jp+81-263-37-2664

Outcome results